Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The impact of greed on academic medicine and patient care

Abstract

To what extent is the increasing emphasis on profit generation at US academic institutions shackling intellectual freedom and compromising healthcare?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The present public-private system for funding and disseminating knowledge.
Figure 2: Potential model of AMC-nonprofit primacy for the development and dissemination of certain US taxpayer–funded innovations for small market sizes.

References

  1. Pisano, G.P. Science Business: The Promise, the Reality, and the Future of Biotech (Harvard Business School Press, Boston, 2006).

    Google Scholar 

  2. Brown, L.D. N. Engl. J. Med. 358, 325–327 (2008).

    Article  CAS  Google Scholar 

  3. Sobolski, G.K., Barton, J.H. & Emanuel, E.J. J. Am. Med. Assoc. 294, 3137–3140 (2005).

    Article  CAS  Google Scholar 

  4. Yancey, A. & Stewart, C.N. Jr. Nat. Biotechnol. 25, 1225–1228 (2007).

    Article  CAS  Google Scholar 

  5. Association of University Technology Managers. FY2006 U.S. Licensing Activity Survey. <http://www.autm.org/events/file/AUTM_06_US20LSS_FNL.pdf> (2006).

  6. Frangioni, J.V. Nat. Biotechnol. 24, 909–913 (2006).

    Article  CAS  Google Scholar 

  7. KSR International Co. v. Teleflex Inc. et al. 550 U.S. 04–1350 <http://www.supremecourtus.gov/opinions/06pdf/04-1350.pdf> (2007).

  8. Ehringhaus, S.H. et al. J. Am. Med. Assoc. 299, 665–671 (2008).

    Article  CAS  Google Scholar 

  9. US Food and Drug Administration. Challenge and opportunity on the critical path to new medical products. <http://www.fda.gov/oc/initiatives/criticalpath/ whitepaper.html#execsummary> (2004).

  10. Henderson, J.A. & Smith, J.J. Academia, industry, and the Bayh-Dole Act: an implied duty to commercialize. <http://www.cimit.org/coi_part3.pdf> (2002).

  11. Wood, A.J. N. Engl. J. Med. 355, 618–623 (2006).

    Article  CAS  Google Scholar 

  12. H.R. 1908. Patent Reform Act of 2007. <http://thomas.loc.gov/cgi-bin/bdquery/z?d110:H.R.1908:> (2007).

  13. Heller, M.A. & Eisenberg, R.S. Science 280, 698–701 (1998).

    Article  CAS  Google Scholar 

  14. Association of Professors of Medicine Physician-Scientist Initiative Consensus Conference, 'Revitalization of the Nation's Physician-Scientist Workforce,' Washington, DC, 25 November 2007.

Download references

Acknowledgements

I thank M.L. Zeidel, R.E. Lenkinski, J.S. Felsch, M.D. Chalek, P.F. Levy, V. Sukhatme, J.S. Flier and M. Rosenberg for many discussions, B.L. Clough and A. Gugelmann for editing, and E. Trabucchi for administrative assistance. I especially thank C.T. Lelon for his thoughtful analysis of capitalism and S.J. Nowak III for his thoughts on profit.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frangioni, J. The impact of greed on academic medicine and patient care. Nat Biotechnol 26, 503–507 (2008). https://doi.org/10.1038/nbt0508-503

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0508-503

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing